Skip to main content
Erschienen in: Digestive Diseases and Sciences 10/2018

22.06.2018 | Original Article

Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis

verfasst von: Adrienne Lenhart, Salwa Hussain, Reena Salgia

Erschienen in: Digestive Diseases and Sciences | Ausgabe 10/2018

Einloggen, um Zugang zu erhalten

Abstract

Background

Acute kidney injury in the setting of alcoholic liver disease portends a poor prognosis without liver transplant.

Aims

Using a tertiary care population, we aimed to evaluate the outcomes of renal replacement therapy in patients with alcoholic liver disease and acute kidney injury with < 6 months sobriety.

Methods

A retrospective review of hospitalized patients with alcoholic hepatitis/acute on chronic alcoholic cirrhosis and hepatorenal syndrome or acute tubular necrosis was performed. Analyzed variables included patient comorbidities, mode of dialysis, MELD-Na score, CLIF-C ACLF score, and CLIF-C OF score.

Results

Forty-seven patients were included, 21.3% of which survived 6 months of sobriety to be eligible for transplant evaluation. Despite renal replacement therapy, mortality was 78.7%. Of survivors, 4 received transplants and 6 recovered without transplant. Lower CLIF-C ACLF (p < 0.001) and CLIF-C OF (p = 0.001) predicted 6-month survival and lower MELD-Na (p = 0.016), CLIF-C ACLF (p < 0.001), and CLIF-C OF (p = 0.006) predicted renal recovery. There was no difference in survival or renal recovery between etiologies of kidney injury. Modality of initial dialysis with intermittent hemodialysis compared to continuous renal replacement therapy predicted improved survival (41.2 vs. 10.0%, p = 0.01) and nearly reached significance for renal recovery (23.5 vs. 6.7%, p = 0.054).

Conclusions

Although severe alcoholic liver disease with acute kidney injury is associated with a high mortality irrespective of the etiology of renal failure, over 20% of patients in this study survived 6 months to be evaluated for liver transplant and 12.8% recovered renal function. These outcomes should be considered when weighing the decision of initiating dialysis.
Literatur
1.
Zurück zum Zitat Witzke O, Baumann M, Patschan D, et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol. 2004;19:1369–1373.CrossRefPubMed Witzke O, Baumann M, Patschan D, et al. Which patients benefit from hemodialysis therapy in hepatorenal syndrome? J Gastroenterol Hepatol. 2004;19:1369–1373.CrossRefPubMed
2.
Zurück zum Zitat Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 2005;68:362–370.CrossRefPubMed Wong LP, Blackley MP, Andreoni KA, Chin H, Falk RJ, Klemmer PJ. Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy. Kidney Int. 2005;68:362–370.CrossRefPubMed
3.
Zurück zum Zitat Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int. 1998;54:518–524.CrossRefPubMed Fraley DS, Burr R, Bernardini J, Angus D, Kramer DJ, Johnson JP. Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation. Kidney Int. 1998;54:518–524.CrossRefPubMed
4.
Zurück zum Zitat Korbet SM, Casey C, Rodby RA, Williams W. The use of continuous arteriovenous hemofiltration in orthotopic liver transplantation. Clin Nephrol. 1995;43:134–136.PubMed Korbet SM, Casey C, Rodby RA, Williams W. The use of continuous arteriovenous hemofiltration in orthotopic liver transplantation. Clin Nephrol. 1995;43:134–136.PubMed
5.
Zurück zum Zitat McCauley J, Gaynord M, Hrinya M, Starzl TE. Dialysis in liver failure and liver transplantation. Transplant Proc. 1993;25:1740.PubMedPubMedCentral McCauley J, Gaynord M, Hrinya M, Starzl TE. Dialysis in liver failure and liver transplantation. Transplant Proc. 1993;25:1740.PubMedPubMedCentral
6.
Zurück zum Zitat Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–974.CrossRefPubMed Angeli P, Gines P, Wong F, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. J Hepatol. 2015;62:968–974.CrossRefPubMed
7.
Zurück zum Zitat Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–1638.CrossRefPubMed Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361:1627–1638.CrossRefPubMed
8.
Zurück zum Zitat Moreau R, Jalan R, Gines P et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437, 1437.e1421–1429.CrossRef Moreau R, Jalan R, Gines P et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013;144:1426–1437, 1437.e1421–1429.CrossRef
9.
Zurück zum Zitat Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012;33:144–148.CrossRefPubMed Gonwa TA, Wadei HM. The challenges of providing renal replacement therapy in decompensated liver cirrhosis. Blood Purif. 2012;33:144–148.CrossRefPubMed
10.
Zurück zum Zitat Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Renal Fail. 2004;26:563–568.CrossRef Capling RK, Bastani B. The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis. Renal Fail. 2004;26:563–568.CrossRef
11.
Zurück zum Zitat Wilkinson SP, Weston MJ, Parsons V, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol. 1977;8:287–292.PubMed Wilkinson SP, Weston MJ, Parsons V, Williams R. Dialysis in the treatment of renal failure in patients with liver disease. Clin Nephrol. 1977;8:287–292.PubMed
12.
Zurück zum Zitat Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. CritCare Med. 1993;21:328–338.CrossRef Davenport A, Will EJ, Davidson AM. Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure. CritCare Med. 1993;21:328–338.CrossRef
13.
Zurück zum Zitat Staufer K, Roedl K, Kivaranovic D, et al. Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications. Liver Int. 2017;37:843–850.CrossRefPubMed Staufer K, Roedl K, Kivaranovic D, et al. Renal replacement therapy in critically ill liver cirrhotic patients-outcome and clinical implications. Liver Int. 2017;37:843–850.CrossRefPubMed
14.
Zurück zum Zitat Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md.). 2001;33:464–470.CrossRef Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology (Baltimore, Md.). 2001;33:464–470.CrossRef
15.
Zurück zum Zitat Huebener P, Sterneck MR, Bangert K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival. Aliment Pharmacol Therap. 2018;47:1502–1510.CrossRef Huebener P, Sterneck MR, Bangert K, et al. Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival. Aliment Pharmacol Therap. 2018;47:1502–1510.CrossRef
16.
Zurück zum Zitat Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583–1593.CrossRefPubMed Asfar P, Meziani F, Hamel JF, et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med. 2014;370:1583–1593.CrossRefPubMed
18.
Zurück zum Zitat Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4:24–34.CrossRefPubMed Tilg H, Day CP. Management strategies in alcoholic liver disease. Nat Clin Pract Gastroenterol Hepatol. 2007;4:24–34.CrossRefPubMed
19.
Zurück zum Zitat Bird GL, O’Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ (Clinical research ed.). 1990;301:15–17.CrossRef Bird GL, O’Grady JG, Harvey FA, Calne RY, Williams R. Liver transplantation in patients with alcoholic cirrhosis: selection criteria and rates of survival and relapse. BMJ (Clinical research ed.). 1990;301:15–17.CrossRef
20.
Zurück zum Zitat Kumar S, Stauber RE, Gavaler JS, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology (Baltimore, Md.). 1990;11:159–164.CrossRef Kumar S, Stauber RE, Gavaler JS, et al. Orthotopic liver transplantation for alcoholic liver disease. Hepatology (Baltimore, Md.). 1990;11:159–164.CrossRef
21.
Zurück zum Zitat Pageaux GP, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut. 1999;45:421–426.CrossRefPubMedPubMedCentral Pageaux GP, Michel J, Coste V, et al. Alcoholic cirrhosis is a good indication for liver transplantation, even for cases of recidivism. Gut. 1999;45:421–426.CrossRefPubMedPubMedCentral
Metadaten
Titel
Chances of Renal Recovery or Liver Transplantation After Hospitalization for Alcoholic Liver Disease Requiring Dialysis
verfasst von
Adrienne Lenhart
Salwa Hussain
Reena Salgia
Publikationsdatum
22.06.2018
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 10/2018
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5170-9

Weitere Artikel der Ausgabe 10/2018

Digestive Diseases and Sciences 10/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.